Wednesday, April 23, 2014

OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, has named Adil Daud, M.D. as Chief Clinical Strategist.



from Content Keyword RSS http://ift.tt/1ieQsqi

via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Total Pageviews

137,747